1. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation 
Jiro Inagaki, Hiroshi Moritake, Takuro Nishikawa, Nobuyuki Hyakuna, Masahiko Okada, So-ichi Suenobu, Kozo Nagai, Yuko Honda, Maiko Shimomura, Reiji Fukano, Maiko Noguchi, Koichiro Kurauchi, Shinji Tanioka, Jun Okamura 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 11, Pages (November 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Outcomes of patients with cGVHD according to the NIH global severity. (A) Cumulative incidence of disease recurrence. (B) Cumulative incidence of NRM. (C) Probability of DFS. (D) Cumulative incidence of cGVHD remission.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Frequency of continuing cGVHD and other events. (A) All events that occurred in patients with mild cGVHD. The probability of continuing cGVHD at 8 years after diagnosis of cGVHD was 3.8% (95% CI, .3 to 16.4). (B) All events in patients with moderate cGVHD. The probability of continuing cGVHD at 8 years was 11.4% (95% CI, 2.9 to 26.3). (C) All events in patients with severe cGVHD. The probability of continuing cGVHD at 8 years was 36.1% (95% CI, 21.9 to 50.4).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions